Inventor · disambiguated record
Bruce A. Malcolm
Also filed as: MALCOLM BRUCE · MALCOLM BRUCE A · MALCOLM BRUCE ALBERT
13 granted patents·15 pending applications·289 citations·filing 1998–2018
92Inventor score
Files withSCHERING CORP17JANSSEN SCIENCES IRELAND UC2MALCOLM BRUCE A2BAERT LIEVEN ELVIRE COLETT1BEYER BRIAN M1
Top patents by PatentIndex Score
28 records- 0196US6911428B2Diaryl peptides as NS3-serine protease inhibitors of hepatitis C virusSCHERING CORP·Filed 2001·Granted Jun 28, 2005·124 cites·20 claims
- 0286US6653127B1Single-chain recombinant complexes of hepatitis C virus NS3 protease and NS4A cofactor peptideSCHERING CORP·Filed 2000·Granted Nov 25, 2003·23 cites·14 claims
- 0385US7569391B2Method for making β-secretase co-crystals complexed with a ligandSCHERING CORP·Filed 2006·Granted Aug 4, 2009·6 cites·1 claims
- 0484US7772178B2Pharmaceutical formulations and methods of treatment using the sameSCHERING CORP·Filed 2006·Granted Aug 10, 2010·17 cites·10 claims
- 0583US6211338B1Single-chain recombinant complexes of hepatitis C virus NS3 protease and NS4A cofactor peptideSCHERING CORP·Filed 1998·Granted Apr 3, 2001·63 cites·11 claims
- 0682US7524831B2Treatments for Flaviviridae virus infectionSCHERING CORP·Filed 2006·Granted Apr 28, 2009·4 cites·26 claims
- 0781US9682096B2Polyinosinic-polycytidylic acid (poly (I:C)) formulations for the treatment of upper respiratory tract infectionsJANSSEN SCIENCES IRELAND UC·Filed 2013·Granted Jun 20, 2017·5 cites·20 claims
- 0876US7816339B2Treatments for Flaviviridae virus infectionSCHERING CORP·Filed 2009·Granted Oct 19, 2010·1 cites·11 claims
- 0976US6251583B1Peptide substrates for HCV NS3 protease assaysSCHERING CORP·Filed 1999·Granted Jun 26, 2001·45 cites·32 claims
- 1066US8063185B2Refolded recombinant β-secretase crystals and methods for preparing and using the sameBEYER BRIAN M·Filed 2009·Granted Nov 22, 2011·0 cites·8 claims
- 1165US9987300B2Polyinosinic-polycytidylic acid (poly (I:C)) formulations for the treatment of upper respiratory tract infectionsBAERT LIEVEN ELVIRE COLETT·Filed 2016·Granted Jun 5, 2018·1 cites·17 claims
- 1263US7166454B1Codon-optimized β-secretase and methods of refolding and processingSCHERING CORP·Filed 2003·Granted Jan 23, 2007·0 cites·20 claims
- 1359US10485816B2Polyinosinic-polycytidylic acid (poly (I:C)) formulations for the treatment of upper respiratory tract infectionsJANSSEN SCIENCES IRELAND UC·Filed 2018·Granted Nov 26, 2019·0 cites·20 claims
- 1454US2006281689A1Method for modulating activity of HCV protease through use of a novel HCV protease inhibitor to reduce duration of treatment periodSCHERING CORP·Filed 2006·Application pending·0 cites
- 1554US2007237818A1Controlled-release formulation of HCV protease inhibitor and methods using the sameMALCOLM BRUCE A·Filed 2006·Application pending·0 cites
- 1653US2007004635A1Method of treating interferon non-responders using HCV protease inhibitorSCHERING CORP·Filed 2006·Application pending·0 cites
- 1750US2006275366A1Controlled-release formulationSCHERING CORP·Filed 2006·Application pending·0 cites
- 1849US2004142322A1Continuous non-radioactive polymerase assaySCHERING CORP·Filed 2003·Application pending·0 cites
- 1945US2004034206A1Combination therapy for RNA virus infections involving ribavirin and IMPDH inhibitorsSCHERING CORP·Filed 2003·Application pending·0 cites
- 2044US2006252698A1Compounds for inhibiting cathepsin activityMALCOLM BRUCE A·Filed 2006·Application pending·0 cites
- 2144US2011033422A1Treatments for flaviviridae virus infectionSCHERING CORP·Filed 2010·Application pending·0 cites
- 2244US2006276406A1Methods of treating hepatitis C virusSCHERING CORP·Filed 2006·Application pending·0 cites
- 2344US2006287248A1Asymmetric dosing methodsSCHERING CORP·Filed 2006·Application pending·0 cites
- 2443US2007224167A1Novel HCV inhibitor combinations and methodsWYETH CORP·Filed 2007·Application pending·0 cites
- 2541US2020060972A1Formulations of polyinosinic acid and polycytidylic acid for the prevention of upper respiratory tract infectionsJANSSEN SCIENCES IRELAND UNLIMITED CO·Filed 2017·Application pending·0 cites
- 2636US2014357577A1HIV Membrane Fusion InhibitorsJANSSEN R & D LTD·Filed 2012·Application pending·0 cites
- 2735US2007274951A1Combinations comprising HCV protease inhibitor(s) and HCV polymerase inhibitor(s), and methods of treatment related theretoTONG XIAO·Filed 2007·Application pending·0 cites
- 2832US2006030550A1Pharmaceutical formulationsLITHGOW THEODORE L·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Bruce A. Malcolm files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →